Recent Federal Bills

Below are summaries of Bills Introduced, Committee Reports, Chamber Actions, and Public Laws reported in the most recent issue of ELR's Weekly Update.

would amend the CWA to establish a Columbia River Basin Restoration Program within EPA.

would require EPA to include an analysis that does not include any other proposed or unimplemented rule in each regulatory impact analysis for a proposed or final rule.

would improve the NOAA's weather research through a focused program of investment on affordable and attainable advances in observational, computing, and modeling capabilities in order to support substantial improvement in weather forecasting and prediction of high impact weather events, and would expand commercial opportunities for the provision of weather data.

would improve NOAA's weather research through a focused program of investment on affordable and attainable advances in observational, computing, and modeling capabilities, would support substantial improvement in weather forecasting and prediction of high impact weather events, and would expand commercial opportunities for the provision of weather data.

would amend the Federal Food, Drug, and Cosmetic Act to enhance the reporting requirements pertaining to use of antimicrobial drugs in food animals.

would authorize the National Capital Planning Commission to designate and modify the boundaries areas of the National Mall in the District of Columbia reserved for the location of commemorative works of preeminent historical significance to the United States, and would require DOI and the General Services Administartion to make recommendations for the termination of the authority of a person to establish a commemorative work in the District of Columbia and its environs.

would designate certain federal portions of the red rock canyons of the Colorado Plateau and the Great Basin Deserts in Utah as wilderness.

would amend the Federal Food, Drug, and Cosmetic Act with respect to valid scientific evidence.

would amend the Federal Food, Drug, and Cosmetic Act with respect to third-party quality system assessments.

would amend the Public Health Services Act to reauthorize funding for the National Institutes of Health.